Regenerative Medical Technology Company
Sign up today and learn more about Humacyte Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Humacyte Stock
Humacyte, Inc. develops products for vascular disease and replacement of anatomical conduits. It offers human tissue-based products called human acellular vessels (HAV) for regenerative medicine and vascular surgery applications. The company was incorporated in 2004 and is headquartered in Morrisville, North Carolina.
Chief Executive Officer
Chief Financial Officer